Soluble E-cadherin and IL-6 serum levels in patients affected by prostate cancer before and after prostatectomy

Author：                  

Publisher： Spandidos Publications

ISSN： 1021-335X

Source： Oncology Reports, Vol.28, Iss.1, 2012-01, pp. : 370-374

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Soluble serum E-cadherin as a marker of tumour progression in colorectal cancer patients

By Wilmanns C.   Grossmann J.   Steinhauer S.   Manthey G.   Weinhold B.   Schmitt-Gräff A.   von Specht B.-U.  

Clinical and Experimental Metastasis, Vol. 21, Iss. 1, 2004-01 ,pp. : 75-78

Springer Publishing Company

Access to resources Recommend Favorite

Relationship between serum IL-18 and VEGF levels in patients with prostate cancer

By Nong Shaojun   Zhang Yueping   Zhou Shujun   Li Wenguang   Ma Limin   Wu You  

The Chinese-German Journal of Clinical Oncology, Vol. 9, Iss. 11, 2010-11 ,pp. : 643-647

Springer Publishing Company

Access to resources Recommend Favorite

IL-6 serum levels predict postoperative morbidity in gastric cancer patients

By Szczepanik Antoni  

Gastric Cancer, Vol. 14, Iss. 3, 2011-08 ,pp. : 266-273

Springer Publishing Company

Access to resources Recommend Favorite

Sulforaphane inhibits invasion by phosphorylating ERK1/2 to regulate E-cadherin and CD44v6 in human prostate cancer DU145 cells

By                

Oncology Reports, Vol. 34, Iss. 3, 2015-01 ,pp. : 1565-1572

Spandidos Publications

Access to resources Recommend Favorite

Soluble interleukin-6 receptor to interleukin-6 (sIL6R/IL-6) ratio in serum as a predictor of high Gleason sum at radical prostatectomy

By                    

Oncology Letters, Vol. 2, Iss. 5, 2011-01 ,pp. : 861-864

Spandidos Publications

Access to resources Recommend Favorite